Treatment of melanoma-associated retinopathy

Current Treatment Options in Neurology

Volumn 12, Issue 1, 2010, Pages 54-63

  Powell, Steven F ^a   Dudek, Arkadiusz Z ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; DIURETIC AGENT; HEPARIN; IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RIFAMPICIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLAXIS; AVASCULAR NECROSIS; BLOOD CLOTTING; BONE NECROSIS; CANCER RADIOTHERAPY; CHILL; CLINICAL ASSESSMENT; CORTICOSTEROID INDUCED MYOPATHY; COST EFFECTIVENESS ANALYSIS; CYTOREDUCTIVE SURGERY; DOSE RESPONSE; DRUG COST; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG POTENTIATION; ELECTRORETINOGRAPHY; ENDOCRINE DISEASE; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPOTENSION; IMMUNE DEFICIENCY; INSOMNIA; LYMPHOCYTE DEPLETION; MANIA; MELANOMA ASSOCIATED RETINOPATHY; METASTASIS; MUSCULOSKELETAL DISEASE; NAUSEA; OSTEOPENIA; OSTEOPOROSIS; PAIN; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PSYCHOSIS; RADIATION RESPONSE; RETINOPATHY; REVIEW; SEIZURE; SIDE EFFECT; SKIN BRUISING; SKIN FRAGILITY; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; STRIA; STROKE; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT CONTRAINDICATION; TREATMENT PLANNING; WOUND HEALING;

EID: 77649271969     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-009-0057-x     Document Type: Review

References (18)

1. JR Heckenlively HA Ferreyra 2008 Autoimmune retinopathy: a review and summary Semin Immunopathol 30 2 127 134 10.1007/s00281-008-0114-7 18408929 This review article explains MAR and other autoimmune retinopathies in regards to diagnosis, pathophysiology, and treatment.
2. JL Keltner CE Thirkill PT Yip 2001 Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases J Neuroophthalmol 21 3 173 187 1:STN:280:DC%2BD3MnnslGnsw%3D%3D 11725182
3. JW Chan 2003 Paraneoplastic retinopathies and optic neuropathies Surv Ophthalmol 48 1 12 38 10.1016/S0039-6257(02)00416-2 12559325 (Pubitemid 36138821)
4. HA Ferreyra T Jayasundera NW Khan, et al. 2009 Management of autoimmune retinopathies with immunosuppression Arch Ophthalmol 127 4 390 397 10.1001/archophthalmol.2009.24 1:CAS:528:DC%2BD1MXltVWgurY%3D 19365013 This article presents a good review of treatment options for the autoimmune retinopathies.
5. M Flynn G Fishman G Adamus 1998 Antiretinal Müller cell antibodies in patients with melanoma-associated and autoimmune retinopathy Invest Ophthalmol Vis Sci 39 10 1976 1979
6. JL Keltner CE Thirkill 1999 The 22 kDa antigen in optic nerve and retinal diseases J Neuroophthalmol 19 71 83 1:STN:280:DyaK1Mzgs1Oqtw%3D%3D 10380127
7. MJ Potter G Adamus SM Szabo, et al. 2002 Autoantibodies to transducin in a patient with melanoma-associated retinopathy Am J Ophthalmol 134 1 128 130 10.1016/S0002-9394(02)01431-9 12095824 (Pubitemid 34722726)
8. C Pföhler KD Preuss W Tilgen, et al. 2007 Mitofilin and titin as target antigens in melanoma-associated retinopathy Int J Cancer 120 4 788 795 10.1002/ijc.22384 17131336 (Pubitemid 46175398)
9. G Ladewig U Reinhold CE Thirkill, et al. 2005 Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV Br J Dermatol 152 5 931 938 10.1111/j.1365-2133.2005.06480.x 1:CAS:528:DC%2BD2MXlsFygs7g%3D 15888149 (Pubitemid 40704933)
10. C Jacobzone C Cochard-Marianowski I Kupfer, et al. 2004 Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings Arch Dermatol 140 10 1258 1261 10.1001/archderm.140. 10.1258 15492190 (Pubitemid 39362245)
11. K Boeck S Hofmann M Klopfer, et al. 1997 Melanoma-associated paraneoplastic retinopathy: case report and review of the literature Br J Dermatol 137 3 457 460 10.1111/j.1365-2133.1997.tb03759.x 1:STN:280: DyaK1c%2FhtVSlsQ%3D%3D 9349350 (Pubitemid 27421581)
12. C Subhadra AZ Dudek PP Rath MS Lee 2008 Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin J Neuroophthalmol 28 1 23 26 18347454 This case report describes the use of IVIG for the treatment of MAR.
13. JS Orange EM Hossny CR Weiler, et al. 2006 Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology: Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology J Allergy Clin Immunol 117 4 Suppl S525 S553 10.1016/j.jaci.2006.01.015 1:CAS:528:DC%2BD28XjtFCqtrk%3D 16580469
14. Eastlund T: Guidelines for Transfusion Therapy, edn 5. Minneapolis, MN: Fairview Laboratory Services; 2007.
15. Testori A, Rutkowski P, Marsden J, et al.: Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol 2009, 20(Suppl 6):vi22-vi29.
16. DW Ollila AS Caudle 2006 Surgical management of distant metastases Surg Oncol Clin N Am 15 2 385 398 10.1016/j.soc.2005.12.003 16632222
17. BC McLeod 1991 The technique of therapeutic apheresis. Removal of abnormal blood elements may succeed when all else fails J Crit Illn 6 5 487 495 1:STN:280:DyaK3sbgt1ClsQ%3D%3D 10147917
18. G Saydain L George S Raoof 2002 New therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies Crit Care Clin 18 4 957 975 10.1016/S0749-0704(02)00028-3 1:CAS:528:DC%2BD38XovFWgsbc%3D 12418449 (Pubitemid 35215570)